SMTL ID : 7nb3.1 (1 other biounit)

Crystal structure of human choline alpha in complex with an inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x U6H: 4-(6-azanyl-2-pyridin-4-yl-purin-9-yl)-~{N}-(3-methoxyphenyl)cyclohexane-1-carboxamide(Non-covalent)

U6H.1: 16 residues within 4Å: Chain A: I.43, R.44, L.51, L.71, R.73, P.121, E.133, Q.134, F.135, I.136, S.138, R.139, R.140, L.240, I.256, D.257 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:R.44, A:F.135, A:L.240, A:I.256 Hydrogen bonds: A:R.44, A:E.133, A:E.133, A:I.136 Water bridges: A:R.140 pi-Cation interactions: A:R.140

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 2 residues within 4Å: Chain A: N.238, D.257 5 PLIP interactions: 1 interactions with chain A, 4 Ligand-Water interactions Metal complexes: A:D.257, H2O.1, H2O.2, H2O.5, H2O.5

2 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)

EPE.3: 10 residues within 4Å: Chain A: D.233, Q.235, E.276, Y.281, W.347, W.350, I.360, F.362, Y.364, Y.367 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:Y.367 Water bridges: A:Q.235, A:Q.235, A:N.272 pi-Cation interactions: A:Y.281, A:F.362 EPE.4: 10 residues within 4Å: Chain A: R.197, Y.286, A.355, S.358, S.359, I.360, F.362, G.363, Y.364, M.365 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:R.197, A:Y.364, A:M.365 Water bridges: A:K.200, A:D.366 Salt bridges: A:R.197

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Quartieri, F. et al., Identification of unprecedented ATP-competitive choline kinase inhibitors. Bioorg.Med.Chem.Lett. (2021)

Release Date

2021-10-13

Peptides

Choline kinase alpha: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
AAA

Choline kinase alpha

Related Entries With Identical Sequence